JSA Peptide · Current catalogue pricing · Malaysia delivery only
JSA Peptide — Science, Wellness, Beauty
Product / Research information

Tirzepatide

Explore Tirzepatide strengths, current prices, research context and safety risks before enquiring.

View products & details Ask a question
Products / Research details

Know the product.
Know the risks.

The notes below are a plain-language overview of common research interest, possible areas of benefit being studied, and known or potential risks. They are not instructions, medical advice, or proof that any product is safe or effective.

JSA Peptide Tirzepatide 20 MG product image

Peptides

Tirzepatide

20 MG

RM 209

About this product

Prescription tirzepatide activates GIP and GLP-1 receptors, reducing appetite, slowing stomach emptying, and improving blood-sugar control. Approved products exist in some markets; this research listing is not a prescription medicine.

Research use & focus

Prescription products including Mounjaro and Zepbound are approved for specific indications in some countries and are used under medical supervision. This research-only listing is not a prescription product or substitute for care.

Potential research outcomes

Approved prescription tirzepatide can support blood-sugar control and weight management for indicated patients. Do not assume this listing has the identity, quality, safety, or clinical effects of approved products.

Possible side effects & safety risks

Prescription labelling includes nausea, vomiting, diarrhoea, constipation, low blood sugar with some medicines, gallbladder problems, pancreatitis, dehydration-related kidney injury, and a thyroid tumour warning based on rat studies.

JSA Peptide Tirzepatide 30 MG product image

Peptides

Tirzepatide

30 MG

RM 289

About this product

Prescription tirzepatide activates GIP and GLP-1 receptors, reducing appetite, slowing stomach emptying, and improving blood-sugar control. Approved products exist in some markets; this research listing is not a prescription medicine.

Research use & focus

Prescription products including Mounjaro and Zepbound are approved for specific indications in some countries and are used under medical supervision. This research-only listing is not a prescription product or substitute for care.

Potential research outcomes

Approved prescription tirzepatide can support blood-sugar control and weight management for indicated patients. Do not assume this listing has the identity, quality, safety, or clinical effects of approved products.

Possible side effects & safety risks

Prescription labelling includes nausea, vomiting, diarrhoea, constipation, low blood sugar with some medicines, gallbladder problems, pancreatitis, dehydration-related kidney injury, and a thyroid tumour warning based on rat studies.

TIRZEPATIDE — Scientific background

GIP / GLP-1 Dual-Receptor Peptide

Scientific background describes the compound, not verified results or quality claims for the supplied vial. Research purposes only; not for human consumption. No self-administration or injection. Research findings do not guarantee individual results.

Tirzepatide is a modified peptide that activates both the GIP and GLP-1 receptors, two key pathways involved in metabolic regulation, appetite signalling and glucose homeostasis.

Its dual-receptor mechanism has been extensively evaluated in clinical research, with studies demonstrating substantial reductions in body weight alongside improvements in multiple metabolic parameters.

Unlike traditional GLP-1 receptor agonists, tirzepatide combines GIP and GLP-1 activity within a single molecule, representing an important development in incretin-based metabolic pharmacology.

Key Characteristics

  • Compound: Tirzepatide
  • Class: Dual GIP/GLP-1 receptor agonist
  • Primary pathways: GIP + GLP-1
  • Research areas: Metabolic regulation, glucose metabolism and body-weight management
  • Clinical development: Extensive Phase 3 evidence
  • Administration: Once-weekly in approved pharmaceutical formulations, not instructions for this research product

Important Notice

Tirzepatide is a prescription medicine.

A non-pharmaceutical research product is not equivalent to an approved tirzepatide medicine. This listing does not imply manufacture, supply or endorsement by the original pharmaceutical developer.

For any product sold as "research purposes only," the product's actual identity, purity, composition and applicable regulatory status should be supported by appropriate documentation such as a batch-specific Certificate of Analysis (COA).

RESEARCH PURPOSES ONLY

Not intended to diagnose, treat, cure or prevent any disease. This information is provided for scientific and educational purposes and does not constitute medical advice.

Not intended to diagnose, treat, cure or prevent any disease. This information is educational and does not constitute medical advice. Refer to the product’s safety risks above and request batch-specific documentation.

Read before enquiring

These products are strictly for research purposes only and are not for human consumption. Do not self-administer, inject, or use them as a substitute for medical care. Product identity, concentration, sterility, legality, and safety can vary. Speak with a licensed healthcare professional for personal health questions.

03 / Enquire privately

Your list.
One clear message.

Select products above, then open WhatsApp with the exact names, strengths, current prices, and research-use notice already included.

Open WhatsApp

Important research notice

All products listed are strictly for research purposes only and are not for human consumption. JSA Peptide does not provide medical advice, diagnosis, treatment, or health claims.